Emerging role of incretin-based therapy as first-line antihypertensives in obesity

Heart. 2024 Sep 16;110(19):1153-1154. doi: 10.1136/heartjnl-2024-324842.
No abstract available

Keywords: Aortic Diseases.

Publication types

  • Editorial

MeSH terms

  • Antihypertensive Agents* / therapeutic use
  • Humans
  • Hypertension* / drug therapy
  • Hypertension* / etiology
  • Incretins* / therapeutic use
  • Obesity* / complications
  • Obesity* / drug therapy
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Incretins